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abstract
 
We studied the regulation of nucleoside transporters in intestinal epithelial cells upon exposure to
either differentiating or proliferative agents. Rat intestinal epithelial cells (line IEC-6) were incubated in the
presence of differentiating (glucocorticoids) or proliferative (EGF and TGF-
 
 
 
) agents. Nucleoside uptake rates
and nucleoside transporter protein and mRNA levels were assessed. The signal transduction pathways used by the
proliferative stimuli were analyzed. We found that glucocorticoids induce an increase in sodium-dependent,
concentrative nucleoside transport rates and in protein and mRNA levels of both rCNT2 and rCNT1, with
negligible effects on the equilibrative transporters. EGF and TGF-
 
 
 
 induce an increase in the equilibrative
transport rate, mostly accounted for by an increase in rENT1 activity and mRNA levels, rENT2 mRNA levels
remaining unaltered. This effect is mimicked by another proliferative stimulus that functions as an in vitro model
of epithelial wounding. Here, rENT1 activity and mRNA levels are also increased, although the signal transduction
pathways used by the two stimuli are different. We concluded that differentiation of rat intestinal epithelial cells is
accompanied by increased mature enterocyte features, such as concentrative nucleoside transport (located at
the brush border membrane of the enterocyte), thus preparing the cell for its ultimate absorptive function. A
proliferative stimulus induces the equilibrative nucleoside activities (mostly through ENT1) known to be located
at the basolateral membrane, allowing the uptake of nucleosides from the bloodstream for the increased demands
of the proliferating cell.
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INTRODUCTION
 
Plasma membrane transporters play a crucial role in
the function of absorptive epithelia, since they mediate
intestinal absorption and renal reabsorption and the
secretion of numerous physiological and pharmaco-
logical compounds. Among these transport systems,
nucleoside transporters are responsible for the uptake
of natural nucleosides and most nucleoside-derived
drugs (Pastor-Angalda et al., 1998; Casado et al., 2002).
There are two main families of nucleoside transport-
ers, concentrative (CNT) and equilibrative (ENT) trans-
porters  (Grifﬁth and Jarvis, 1996; Ritzel et al., 1998;
Pastor-Angalda and Baldwin, 2001). Concentrative
nucleoside transport activities have been identiﬁed in
intestinal epithelial cells in several species, including
mouse
 
 
 
(Vijayalakshmi and Belt, 1988), rat (Iseki et al.,
1996), human (Chandrasena et al., 1997; Patil and
Unadkat, 1997), and pig (Scharrer et al., 2002). These
activities, at least in humans, seem to follow a proximal-to-
distal gradient, with maximal transport rates in the
jejunum (Ngo et al., 2001). Alongside this activity, the
mRNA and protein of the pyrimidine-preferring CNT1
tansporter (Huang et al., 1994) and the purine-preferring
CNT2 transporter (Ritzel et al., 1998; Valdés et al., 2000)
have also been detected in the small intestine. In the
kidney, the pattern of nucleoside transporter expression
appears to be more complex, since CNT2 has been
detected in human kidney (Ward and Tse, 1999), but
its activity is not always measurable (Gutierrez et al.,
1992); its protein has not been detected in crude ho-
mogenates from rat kidney (Valdés et al., 2000). Addi-
tionally, a novel concentrative nucleoside transporter
activity, termed N4, has been described in human kid-
ney, but still remains to be identiﬁed at the molecular
level (Gutierrez and Giacomini, 1993).
The presence of equilibrative transporters (both
ENT1 and ENT2) in absortive epithelial cells suggests
the possibility of a transepithelial, vectorial transfer of
nucleosides (Williams et al., 1989; Mangravite et al.,
2003a). This hypothesis is controversial, however, since
the intracellular metabolism of nucleosides appears too
fast to allow such a ﬂow from the apical to the basal
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membrane. Concentrative transporters seem to be re-
stricted to the apical membrane of polarized epithelial
cells (Patil and Unadkat, 1997; Ward and Tse, 1999),
but there remains some controversy about the localiza-
tion of equilibrative transporters (Trimble and Coul-
son, 1984; Doherty and Jarvis, 1993; Williams et al.,
1989). The use of ﬂuorescently tagged nucleoside trans-
porters has not produced unequivocal results, since
hCNT1 seems restricted to the apical membrane (Lai
et al., 2002) and hENT2 to the basolateral domain
(Mangravite et al., 2003b); hENT1 was described in the
former report as being localized in the basolateral
membrane and in the latter as being in both the apical
and the basolateral membranes.
To date, the regulation of nucleoside transporters in
epithelia has not been studied in depth. Nucleoside
transport is sensitive to substrate availability in the
small intestine. rCNT1 protein levels and activity are in-
creased during fasting (Valdés et al., 2000), and this
regulation is exerted, at least partially, by nucleosides,
since the administration of a semipuriﬁed, nucleoside-
free diet induced an increase in jejunal CNT1 expres-
sion and activity in rats (Valdés et al., 2000). The high
sensitivity of CNT1 to nutrient availability may have
clinical relevance, since it is involved in the uptake of
most ﬂuoropyrimidines used in cancer treatment (Pas-
tor-Angalda et al., 1998; Baldwin et al., 1999), and gem-
citabine uptake is enhanced in brush border vesicles
from fasted rats (Valdés et al., 2000), although this
drug is not administered orally. Endocrine regulation
of these transporters in intestinal cells has only been re-
ported once, where it was shown that glucocorticoids,
insulin, and epidermal growth factor increase CNT2 ac-
tivity in the rat small intestine–derived cell line IEC-6
(Jakobs et al., 1990).
In the present study, we have fully characterized the
expression pattern of nucleoside transporters in IEC-6
cells. We have also shown that glucocorticoids, well-
known differentiation agents for intestinal cells, in-
crease CNT2 expression and activity, while epidermal
growth factor (EGF) and transforming growth factor
(TGF) 
 
 
 
, potent mitogens for enterocytes, do not affect
concentrative transport but instead induce the expres-
sion and activity of ENT1, an effect mimicked by an-
other enterocyte proliferative stimulus such as epithe-
lial wounding. These results may be important for the
improvement of nucleoside-derived drug delivery in
anti-tumoral and anti-viral therapies.
 
MATERIALS AND METHODS
 
Materials
 
Cell culture reagents were purchased from Invitrogen. PD98059
was obtained from Calbiochem. SP600125 was from Biotrend.
Antibodies against total or phosphorylated forms of extracellu-
larly-regulated kinase (ERK) 1/2 were purchased from Promega.
 
3
 
H-Uridine and 
 
3
 
H-guanosine were from Amersham Biosciences
while 
 
3
 
H-cytidine was purchased from Nucliber. Dexamethasone,
EGF, and TGF-
 
 
 
 were from Sigma-Aldrich. All other reagents
were of analytical grade.
 
Cell Culture and Treatments
 
IEC-6 cells (derived from crypt cells of the rat small intestine)
were cultured in DMEM supplemented with 5% (by volume) FCS
(or 0.2% BSA in some treatments), 1 mM sodium pyruvate, 4
mM glutamine, 0.1 U/ml bovine insulin, and a mixture of antibi-
otics and antimicotics. For dexamethasone treatment, cells were
kept overnight in a serum-free, BSA-containing medium, and
then dexamethasone was added at a ﬁnal concentration of 100
nM for 24–48 h. Transport of 1 
 
 
 
M guanosine was then mea-
sured and protein and RNA extracts were obtained. Protein ex-
tracts were prepared in a lysis buffer containing 0.3 M sucrose, 25
mM imidazole (pH 7.2), 1 mM EDTA, aprotinin (2 
 
 
 
g/ml), leu-
peptin (10 
 
 
 
M), and AEBSF (1 mM). A 30-
 
 
 
g aliquot was used
for analysis of rCNT2 protein by Western blot using a monospe-
ciﬁc polyclonal rabbit antibody characterized elsewhere (Valdés
et al., 2000). RNA extracts taken at different time points were
prepared with the SV Total Isolation System (Promega) accord-
ing to the manufacturer’s instructions.
For EGF and TGF-
 
 
 
 treatments, cells were also serum deprived
overnight and then either EGF (ﬁnal concentration 20 ng/ml)
or TGF-
 
 
 
 (10 ng/ml) was added. In some experiments, the
ERK1/2 inhibitor PD98059 or the JNK1/2/3 inhibitor SP600125
was added at a ﬁnal concentration of 10 
 
 
 
M and 20 
 
 
 
M, respec-
tively, 30 min before growth factor addition. The epithelial
wounding model (McCormack et al., 1992; Ciacci et al., 1993)
consisted of a series of parallel cuts performed with a razor blade
in the monolayer of cells (50–70 cuts per 2 cm
 
2
 
 dish), which had
been deprived of serum for 12 h; PD98059 was also added to
some dishes under the same conditions as stated before.
 
Measurement of Transport Activity
 
Nucleoside transport activity was measured at a substrate concen-
tration of 1 
 
 
 
M for all nucleosides and a speciﬁc activity of 30 Ci/
mmol (for uridine), 15 Ci/mmol (for guanosine), or 21.5 Ci/
mmol (for cytidine), in the presence of either 137 mM sodium
chloride or 137 mM choline chloride, as described elsewhere
(del Santo et al., 1998). Uridine was used as a common permeant
for CNTs and ENTs (ENT1 and ENT2 activities were discrimi-
nated using 1 
 
 
 
M nitrobenzyl-thioinosine [NBTI]), and, since
CNT3 was shown to be absent, sodium-dependent guanosine
transport could be used as a CNT2-speciﬁc measure and sodium-
dependent cytidine transport as a CNT1-speciﬁc measure. The
uptake medium also contained 5.4 mM KCl, 108 mM CaCl
 
2
 
, 1.2
mM MgSO
 
4
 
, and 10 mM HEPES, (pH 7.4). Transport measure-
ment was stopped after 1 min incubation by washing the cells
twice with 2 ml of a cold buffer containing 137 mM NaCl and 10
mM Tris-HEPES, pH 7.4. Cells were then dissolved in 100 ml of
100 mM NaOH, 0.5% Triton X-100, and aliquots were taken for
protein determination (Bradford assay; BioRad Laboratories)
and for radioactivity measurements.
 
Reverse Transcription and RT-PCR
 
1 
 
 
 
g of total RNA was used for cDNA synthesis using the TaqMan
Reverse Transcription System (Applied Biosystems), according
to the manufacturer’s instructions. Oligonucleotide primer se-
quences for RT-PCR were as follows: CNT1 forward 702–725
(tttgcaggcatctgtgtgttcct) and reverse 1272–1295 (caacgcacaa-
ggggcggccatgac); CNT2 forward 776–799 (gctcaaaggccagagcagct-
gatc) and reverse 1442–1445 (cagcttcactccctccttgctctt); ENT1 
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forward 5–25 (atgacaaccagtcacc) and reverse 1352–1375 (tcct-
tcttgttaagggcacttgtg); ENT2 forward 356–376 (aacaactgggtgacact-
gctgt) and reverse 1379–1400 (ggctacttcgtgtctctcacca). RT-PCR
was performed in a Thermocycler (Applied Biosystems), and the
polymerase used was TaqDNA polymerase (Promega).
 
Real-time RT-PCR
 
The primers and probes used to amplify cDNA by real-time RT-
PCR were designed using Primer Express software and the se-
quences employed were as follows: rGAPDH forward 30–50
(gatggtgaaggtcggtgtcaa), reverse 115–91 (caaatgtccacttgtcacaa-
gagaa), probe 70–89 (ccgcctggtcaccagggctgc); rCNT2 forward
785–803 (tgcgggaatctgcatgtt), reverse 854–836 (ctccagctcaccg-
cactgt), probe 805–831 (atcctcatcctctttgcctgctccaaa); rENT1 for-
ward 765–785 (gtgaaggagaggagccaagag), reverse 836–817 (tgttg-
gcgggtagagagagagttg), probe 807–789 (accccagattcctctcttc); and
rENT2 forward 923–943 (ggcccaactctggatcttgac), reverse 990–
979 (cctggcttctgtggttcct), probe 968–945 (ctccagctccttctctg). Real-
time monitoring of PCR ampliﬁcation of cDNAs was performed
with the TaqMan Universal Master Mix (Applied Biosystems) us-
ing 150 nM probe and 700 nM each primer, in the ABI Prism
7700 Sequence Detection System (Applied Biosystems). The rela-
tive quantiﬁcation of gene expression was performed according
to the manufacturer’s instructions using rat glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) as an internal control. The
threshold cycle (CT) is deﬁned as the cycle number at which the
ﬂuorescence corresponding to the ampliﬁed PCR product is ﬁrst
detected. The results are given as PCR arbitrary units of each
transporter after normalizing the mRNA levels of these genes to
the GAPDH expression levels.
 
Analysis of ERK1/2 Phosphorylation
 
IEC-6 cells were incubated under the various conditions tested
and then treated with Triton lysis buffer (50 mM HEPES, pH 7.4,
150 mM NaCl, 100 mM NaF, 10 mM EDTA, 10 mM Na
 
4
 
P
 
2
 
O
 
7
 
, 2
mM Na
 
3
 
VO
 
4
 
, 1% Triton X-100, 2 
 
 
 
g/ml aprotinin, 10 
 
 
 
M leu-
peptin, and 1 mM AEBSF) at selected times for the ﬁrst 30 min
after treatment. Extracts were then centrifuged for 5 min at
12,000 rpm, their protein contents measured, and 15 
 
 
 
g or 40 
 
 
 
g
of the supernatants used for analysis of total or active ERK1/2,
respectively, by Western blot.
 
RESULTS
 
Characterization of Nucleoside Transport in IEC-6 Cells
 
The pattern of nucleoside transporters present in con-
ﬂuent monolayers of IEC-6 cells was studied in differ-
ent ways. 
 
3
 
H-Uridine was used as a common permeant
for the main nucleoside transport systems and its up-
take was inhibited by adding nonradioactive nucleo-
sides to the transport medium (Fig. 1 A). As deduced
from these results, IEC-6 cells exhibit both sodium-
dependent and sodium-independent nucleoside trans-
port activities that are compatible with the coexistence
of at least three different transport systems: a purine,
sodium-dependent activity and both NBTI-sensitive
and NBTI-resistant systems. This functional evidence
was conﬁrmed by studying the expression pattern of
nucleoside transporters in IEC-6 cells. CNT2, ENT1,
and ENT2 were easily detected by RT-PCR (Fig. 1 B),
while CNT1 only appeared as a faint band that was not
always detectable. CNT expression was also analyzed by
Western blot (Fig. 1 C). CNT2 protein was the predom-
inant concentrative nucleoside transporter observed,
although some expression of CNT1 protein was also
detected.
 
Effect of Dexamethasone Treatment on Nucleoside Transport 
in IEC-6 Cells
 
Guanosine transport was measured in IEC-6 cells at dif-
ferent time intervals (24 and 48 h) after addition of 100
nM dexamethasone (Fig. 2 A). Sodium-dependent gua-
nosine transport (i.e., CNT2 activity) predominated,
representing 
 
 
 
90% of the total transport capacity of
the cells, and it was further increased by dexametha-
sone (
 
 
 
60% at 24 h and near to 100% at 48 h). Al-
though much lower in absolute value, equilibrative
transport of guanosine was also increased by a similar
proportion in response to dexamethasone. In accor-
dance with these data, CNT2 mRNA and protein lev-
els were also increased by dexamethasone treatment
(three- and fourfold at 24 and 48 h, respectively), as
Figure 1. Characterization of nucleoside transporter activity and
expression in IEC-6 cells. (A) Inhibition of uridine uptake by
selected nucleosides and derivatives: guo, guanosine; cyt, cytidine;
thy, thymidine; NBTI, nitrobenzyl thioinosine. Open bars, sodium-
dependent uridine uptake; solid bars, sodium-independent
uridine uptake. (B) RT-PCR of rCTN1, rCNT2, rENT1, and
rENT2 performed on RNA from monolayers of IEC-6 cells. (C)
Western blot of rCNT1 and rCNT2 performed on protein extracts
from monolayers of IEC-6 cells. Protein extracts from rat
hepatocytes were used as positive controls. 
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shown by the results obtained with real-time RT-PCR
(Fig. 2 B) and Western blot (Fig. 2 C). Dexamethasone
treatment also increased the levels of CNT1 mRNA and
activity, although this latter effect (measured as so-
dium-dependent cytidine transport) remained at al-
most undetectable levels (2.9 
 
 
 
 0.3 vs. 1.5 
 
 
 
 0.1, in the
presence or absence of dexamethasone, respectively),
corresponding to 
 
 
 
2% of the activity observed for
CNT2.
 
Effect of Proliferation Induction on Nucleoside Transport in 
IEC-6 Cells
 
Neither CNT2 activity nor its protein and mRNA levels
were altered after a 10-h treatment of IEC-6 cells with
either EGF or TGF-
 
 
 
 (unpublished data). Instead,
treatment with either growth factor resulted in an in-
crease in sodium-independent uridine transport. When
analyzed in more detail, only the NBTI-sensitive com-
ponent of equilibrative uridine transport (i.e., ENT1
activity) was responsible for this increase (Fig. 3 A),
while the NBTI-resistant component (i.e., ENT2 activ-
ity) was unaltered by either treatment, at least at the
growth factor concentrations used (Fig. 3 B). By real-
time RT-PCR, it could be shown that only ENT1 mRNA
levels were increased in response to growth factor addi-
tion, while the levels of ENT2 mRNA remained con-
stant (Table I).
The effects of EGF and TGF-
 
 
 
 on ENT1 expression
and activity were mimicked by a model of epithelial
wounding (Fig. 4). Again, an increase in ENT1, but not
in ENT2 (not depicted), activity was detected 10 h after
injuring the cells (Fig. 4 A), and this change was paral-
leled by an increase in ENT1 mRNA levels (Fig. 4 B).
Since all these proliferative stimuli are known to acti-
vate the mitogen-activated protein (MAP) kinase path-
Figure 2. Effect of dexamethasone on nucleoside transport in
IEC-6 cells. (A) Effect of different times of dexamethasone
treatment in the uridine uptake of IEC-6 cells. Cells were treated
with dexamethasone for 24 or 48 h and then nucleoside uptake
was measured. Solid bars, CNT2 activity measured as sodium-
dependent guanosine uptake (control uptake rate: 111   7 pmol/
min/mg protein). Open bars, equilibrative activity measured as
sodium-independent guanosine uptake (control uptake rate: 14  
1 pmol/min/mg protein). Statistical analysis by Student’s t test: *,
P   0.05; **, P   0.01, vs. control values. (B) rCNT2 mRNA
expression levels after dexamethasone treatment of IEC-6 cells
determined by real-time PCR. Values are corrected by PCR internal
control and normalized to control values (expressed as unity).
Measurements were performed in triplicate on RNA from IEC-6
monolayers. (C) rCNT2 protein analysis by Western blot on
IEC-6 cells after no exposure (ctrl) or after 24 h exposure to
dexamethasone (dexa).
Figure 3. Effect of EGF and TGF  on nucle-
oside transport in IEC-6 cells. (A) Effect of
growth factors on ENT1 activity in monolayers
of IEC-6 cells and the effect of ERK1/2 or
JNK/1/2/3 inhibition. Open bars, no inhibi-
tor; solid bars, 30 min preincubation with the
ERK1/2 inhibitor PD98059; striped bars, 30
min preincubation with the JNK/1/2/3 inhib-
itor SP600125. Statistical analysis by Student’s t
test: **, P   0.01, growth factor vs. control;
†, P   0.05, ††, P   0.01, inhibitor vs. no inhib-
itor. (B) Effect of growth factors on ENT2 ac-
tivity in monolayers of IEC-6 cells and the
effect of ERK1/2 inhibition. Open bars, no in-
hibitor; solid bars, 30 min preincubation with
the ERK1/2 inhibitor PD98059; striped bars,
30 min preincubation with the JNK/1/2/3 in-
hibitor SP600125. (C) Effect of growth factor
treatment on ERK1/2 activation in IEC-6 cells.
Monolayers of IEC-6 cells were exposed to the
different treatments and, at given times,
protein extracts were prepared and total
ERK1/2 (15  g of protein extract) and phos-
phorylated ERK1/2 (40  g of protein extract)
levels were analyzed by Western blot. 
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way in the intestine, the possible involvement of these
protein kinases in this ENT1 response was tested. Both
growth factor incubation and epithelial wounding re-
sulted in an increase in the phosphorylated form of
ERK1/2 as early as 5–10 min after the beginning of the
stimulus (Fig. 3 C and Fig. 4 C). Blocking the activity of
ERK1/2 with the inhibitor PD98059 resulted in a loss
of the effect on ENT1 activity in response to either
growth factors (Fig. 3 A) or epithelial wounding (Fig. 4
A). The response of ENT1 mRNA levels, however, was
different in both models. PD98059 caused a decrease
in the basal levels of ENT1 mRNA in IEC-6 cells (Table
I). However, while it completely suppressed the induc-
tion of ENT1 mRNA in the epithelial injury model
(Fig. 4 B), the threefold induction of ENT1 mRNA in
response to EGF and TGF-
 
 
 
 treatments was unaltered
(Table I). JNK1/2/3 inhibition had a different effect:
the addition of the inhibitor SP600125 induced an in-
crease in ENT1 mRNA levels and activity (Table I), but
had no effect on the response to either growth factor.
 
DISCUSSION
 
Absorptive epithelial cells rely on membrane transport-
ers to accomplish their most characteristic function.
For some metabolites like glucose, the presence of so-
dium-dependent, concentrative transporters at the api-
cal membrane ensures full absorption of nutrients,
while sodium-independent equilibrative transporters
release these nutrients to the bloodstream at the basal
membrane (Quaroni et al., 1979). The human intes-
tine expresses both concentrative and equilibrative nu-
cleoside transporters (Chandrasena et al., 1997; Patil
and Unadkat, 1997); the sodium-dependent nucleoside
transporters are distributed along a longitudinal gradi-
ent, with higher activities in the most proximal regions
of the small intestine (Ngo et al., 2001). It has recently
been suggested that such a dual distribution of concen-
trative and equilibrative transporters exists in intestinal
epithelial cells (Williams et al., 1989), although in renal
epithelial cells this pattern is less clear (Lai et al., 2002;
Mangravite et al., 2003b). This differential location of
nucleoside transporters at both membranes supports
the suggestion of a transepithelial ﬂux of nucleosides,
as already shown for some substrates in kidney cells
(Mangravite et al., 2003a; Lai et al., 2002), although the
rapid intracellular metabolization of nucleosides ar-
gues against this possibility. Thus, the need for good ab-
sorptive cell models to study nucleoside transport is
evident.
The expression pattern of nucleoside transporters in
the rat intestinal epithelial cell line IEC-6 has been
poorly characterized (Jakobs et al., 1990). In this study,
we have performed a full characterization of this cell
model, conﬁrming the existence of a purine-prefer-
ring, sodium-dependent activity that is consistent with
the expression of CNT2, shown by RT-PCR and Western
blot. Furthermore, we have demonstrated the existence
of two equilibrative activities, both NBTI sensitive and
resistant, consistent with the expression of ENT1 and
 
TABLE I
 
Effect of EGF and TGF
 
 
 
 on Nucleoside Transporter mRNA Levels in
IEC-6 Cells and the Effect of ERK1/2 and JNK1/2/3 Inhibition
 
No inhibitor PD98059 SP600125
Control 0.97 
 
 
 
 0.02 0.56 
 
 
 
 0.06
 
f
 
4.21 
 
 
 
 0.26
 
f
 
EGF 5.01 
 
 
 
 0.31
 
c
 
1.72 
 
 
 
 0.14
 
b,f
 
8.40 
 
 
 
 0.96
 
a
 
TGF
 
 
 
4.46 
 
 
 
 0.63
 
b
 
1.59 
 
 
 
 0.19
 
b,d
 
9.29 
 
 
 
 0.88
 
b,e
 
Real-time PCR data are given in arbitrary units, normalized to the values
obtained with untreated (control) cells in the absence of any inhibitor.
Statistical analysis was by Student’s 
 
t
 
 test.
 
a
 
P 
 
 
 
 0.05, growth factor vs. control.
 
b
 
P 
 
 
 
 0.01, growth factor vs. control.
 
c
 
P 
 
 
 
 0.001, growth factor vs. control.
 
d
 
P 
 
 
 
 0.05, vs. no inhibitor.
 
e
 
P 
 
 
 
 0.01, vs. no inhibitor.
 
f
 
P 
 
 
 
 0.001, vs. no inhibitor.
Figure 4. Effect of epithelial wounding on nucleoside transport
in IEC-6 cells. (A) Effect of an epithelial wounding model on
rENT1 activity in monolayers of IEC-6 cells and the effect of
ERK1/2 inhibition. Open bars, no inhibitor; solid bars, 30 minute
pre-incubation with the ERK1/2 inhibitor PD98059. Statistical
analysis by Student’s t-test: *, P   0.05, wound vs. control; †, P  
0.05, inhibitor vs. no inhibitor. (B) Effect of epithelial wounding
on rENT1 mRNA levels and the effect of ERK1/2 inhibition,
determined by real-time PCR. Open bars, no inhibitor; solid bars,
30 minute preincubation with the ERK1/2 inhibitor PD98059.
Statistical analysis by Student’s t-test: *, P   0.05, wound vs. control;
††, P   0.01, †††, P   0.001 inhibitor vs. no inhibitor. (C) Effect
of epithelial wounding on ERK1/2 activation in IEC-6 cells.
Monolayers of IEC-6 cells were exposed to the different treatments
and, at given times, protein extracts were prepared and total
ERK1/2 (15 mg of protein extract) and phosphorylated ERK1/2
(40 mg of protein extract) levels were analyzed by Western blot.  
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ENT2, respectively. Although some CNT1 mRNA and
protein can be detected by RT-PCR and Western blot,
no signiﬁcant activity could be measured using cytidine
as substrate.
The acquisition of intestinal digestive and absorptive
properties is intimately linked to the degree of differ-
entiation. Thus, immature crypt cells express few ma-
ture enterocytic features, such as sucrase–isomaltase
complex activity or even a well-organized brush border
at the luminal surface (Quaroni et al., 1979; Issel-
bacher, 1974). These functions are acquired during the
migration of the cells along the crypt–villus axis. The
IEC-6 cell line is derived from crypt cells and so it
shares many of the undifferentiated characters typical
of the immature enterocyte (Quaroni et al., 1979). One
of the best characterized maturation agents for intesti-
nal cells are glucocorticoids (Blake and Henning,
1983), either directly or through the stimulation of
cell–cell and cell–matrix interactions (Louvard et al.,
1992; Simo et al., 1992). IEC-6 cells also respond to glu-
cocorticoids with cell cycle withdrawal and ultrastruc-
tural changes (Quaroni et al., 1999), although no in-
duction of brush border enzymatic activities could be
detected, possibly due to the failure to establish con-
tacts with the basement membrane or with mesenchy-
mal cells. Glucocorticoids did not elicit the appearance
of sodium-dependent glucose transport in IEC-6 cells
either (Inui et al., 1980), but they seem to increase the
levels of previously expressed transporters (Iannoli et
al., 1998). In agreement with this latter report, we have
shown that dexamethasone treatment of IEC-6 cells
clearly increases both CNT2 expression and activity
and also boosts CNT1 expression. The fact that CNT1
activity is not measurable even after dexamethasone
treatment might be explained by a failure to insert the
transporter molecules into the membrane correctly. In-
tracellular trafﬁcking of CNT1 molecules is much more
complex than that of CNT2 and most of the protein re-
mains in intracellular structures (Duﬂot et al., 2002).
Our results would thus support a direct role of gluco-
corticoids in the regulation of some mature enterocyte
features in IEC-6 cells and are in agreement with our
previous results showing that CNT expression is di-
rectly dependent upon glucocorticoid regulation (del
Santo et al., 2001).
A very different response is observed after EGF or
TGF-
 
 
 
 treatment of IEC-6 cells. EGF and TGF-
 
 
 
 are
among the most potent proliferative agents for intesti-
nal epithelial cells, both in vivo (Koyama and Podolsky,
1989; Hirano et al., 1995; Dignass et al., 1996) and in
vitro (Rokutan et al., 1994; Riegler et al., 1996; Dionne
et al., 1998). The proliferation induced by TGF-
 
 
 
 seems
to be regulated by the autocrine production of TGF-
 
 
 
.
Thus, it is initially self-maintained, but is ultimately
down-regulated by the production of the growth-arrest-
ing TGF-
 
 
 
 signal (Suemori et al., 1991). Treatment of
IEC-6 cells with either EGF or TGF-
 
 
 
 had little effect
on concentrative nucleoside transporters, but elicited a
more than twofold increase in ENT1 activity and
mRNA levels. This result is in clear support of a role for
ENT1 as the main nucleoside purveyor for cell prolifer-
ation, as previously reported in macrophages (Soler et
al., 2001).
Epithelial intestinal cell proliferation can be elicited
in vivo by mucosal damage (Feil et al., 1987; Lacy,
1988), and an in vitro model of epithelial wounding
has been developed in IEC-6 cells (McCormack et al.,
1992; Ciacci et al., 1993). Many growth factors and cyto-
kines have been shown to mediate the proliferative re-
sponse to mucosal wounding, such as TGF-
 
 
 
, TGF-
 
 
 
,
EGF, hepatocyte growth factor, acidic and basic ﬁbro-
blast growth factors, and IL-1
 
  
 
(Dignass and Podolsky,
1993; Dignass et al., 1994), although EGF does not
seem to reduce chemotherapy-induced intestinal injury
(Huang et al., 2002). In vitro wounding of IEC-6 cells
also resulted, as in the treatments with EGF or TGF-
 
 
 
,
in an increase in ENT1 activity, but without any effect
on concentrative transporters. Thus, both proliferative
stimuli induce the equilibrative transport that has been
reported previously to be present in the basolateral
membrane of the epithelial cell (Lai et al., 2002; Man-
gravite et al., 2003b), presumably to ensure nucleoside
supply for proliferation that would have been derived
from the bloodstream had this stimulus occurred in
vivo. In this context, it has been shown that supplemen-
tation of parenteral nutrition formulae with nucleo-
sides or nucleotides greatly ameliorates intestinal mu-
cosa atrophy caused by total parenteral nutrition (Iwasa
et al., 2000).
Both TGF-
 
 
 
 and epithelial injury are known to stimu-
late the mitogen-activated protein (MAP) kinase cas-
cade in IEC-6 cells (Dionne et al., 1998; Oliver et al.,
1994; Göke et al., 1998). In our model, both kinds of
stimuli increased the phosphorylation level of ERK1/2,
and, as might have been expected, blocking of ERK1/2
activity resulted in a loss of the effect of wounding on
ENT1 mRNA and activity. However, the same effect was
not observed after growth factor treatment, where only
a decrease in ENT1 activity, but not in mRNA expres-
sion level, was observed. So, while the wounding effects
on ENT1 can be explained by an increase in its gene
transcription rate mediated by ERK1/2, the effects trig-
gered by EGF and TGF
 
 
 
 must use a different signal
transduction pathway. This alternate pathway is not me-
diated by JNK, since its inhibition had no effect on
growth factor induction of ENT1 expression. Although
we have tested a battery of different possible pathways
(PI3 kinase, PKC, PKA, Tor kinase, and p38; unpub-
lished data), the identity of this mediator still remains
elusive. 
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In conclusion, induction of differentiation of IEC-6
cells results in an increase in the expression and activity
of mature enterocyte nucleoside transporters such as
CNT2 (and to a lesser extent CNT1), concentrative
transporters located at the apical membrane of the en-
terocyte where they participate in the absorption of
dietary nucleosides. In contrast, a proliferative signal
such as epithelial wounding or growth factor exposure
induces an increase in the expression and activity of
ENT1, a basolateral nucleoside transporter, probably
involved in the release of absorbed nucleosides or, as in
this case, in the uptake of circulatory nucleosides to
support the increased proliferation rate of these cells.
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